Relevance of CYP2C9 Function in Valproate Therapy.

Abstract excerpt

BACKGROUND: Genetic polymorphisms of drug metabolizing enzymes can substantially modify the pharmacokinetics of a drug and eventually its efficacy or toxicity; however, inferring a patient's drug metabolizing capacity merely from his or her genotype can lead to false prediction. Non-genetic host factors (age, sex, disease states) and environmental factors (nutrition, comedication) can transiently alter the enzyme...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age Factors
• Share to Anticonvulsants
• Share to Biosynthetic Pathways